Anagenics Limited · ASX:AN1
Anagenics — Q3 2025 Earnings Presentation
15 slides from Anagenics's earnings presentation, May 5, 2025
Slide 1: 3Q25 Update
5 May 2025 3Q25 Update Anagenics Limited (ASX: AN1)
Slide 2: Portfolio of innovative health, beauty and wellness brands
Anagenics is developing a portfolio of innovative health, beauty, and wellness brands and solutions PRIORI /skin uSDa. regimen/Lx MANDA
Slide 3: Income Statement
Restructure Income Statement Commences A$’000 FY24 1Q25 2Q25 3Q25 FY25 YTD Following the recent restructure, Operating Expenses Revenue 10,803 1,422 1,263 893 3,578 have been recalibrated to 25% of 1Q25 levels while Cost of Sales (6,442) (857) (489) (437) (1,783) Revenue & Other Income remains at 63
Slide 4: Total Operating Expenses / Revenue & Other Income
Total Operating Expenses / Revenue & Other Income Operating Expenses (monthly average) 109.6% 106.8% $721k $560k 52.4% 42.0% $227k $139k FY24 1Q25 2Q25 3Q25 FY24 1Q25 2Q25 3Q25 Note: Includes Business Restructure Expense Note: Excludes Business Restructure Expense May 2025
Slide 5: Balance Sheet
Balance Sheet The recent restructure has driven a marked improvement in the Anagenics balance sheet over recent quarters. A$’000 FY24 1Q25 2Q25 3Q25 This has been achieved via a significant reduction in Cash and cash equivalents 1,624 589 471 367 Liabilities, with Trade Payables down 59% since 1Q25,
Slide 6: Operating Cash Flow ($k)
Operating Cash Flow ($k) 1Q25 2Q25 3Q25 Operating Cash Outflows have improved materially as a result of the restructure. During 3Q25, Operating Cash Flow was negatively impacted by efforts to reduce (356) (424) historical liabilities. Excluding this, Operating Cash Flow for the quarter would have be
Slide 7: During FY25, Anagenics has:
Change picture During FY25, Anagenics has: - Rationalised the brand portfolio, which has improved profitability and working capital management - Signed a multi-year exclusive agreement with Sydney-based York Street Brands for access to Anagenics’ hair regrowth technology and products, targeting a mi
Slide 8: Management and board focus following the restructure
With the business restructure now largely complete, the management and board of Anagenics are focused on: Maintaining recent profitability - Based on recent cost improvements and royalty wins Reinforcing royalty revenue streams - Targeting new agreements per the recent York Street Brands deal New br
Slide 9: Key Brands
Slide 10: Key brand descriptions
French Marine Skincare founded in 1964, Italian vegan & highly concentrated natural Pioneer in biotech-based skincare innovation; specialising in products made with algae and skincare with over 25 years in the spa and looks at skin’s biological structure & metabolism marine extracts wellness sector
Slide 11: Haircare brand products and formulations
Products are formulated for daily rituals that promote strong, vibrant Anti-ageing hair care collection focused on harnessing the latest hair, especially for those with long hair or those aspiring to grow it scientific research to give thicker, stronger, healthier hair. Their longer. Each product is
Slide 12: 7
7
Slide 13: Key Strategic Growth Pillar: Exclusive House of Brands
Commitment to “Exclusive House of Brands” Strategy 2025 launch of premium Norwegian haircare brand Manda. Ongoing commitment to health and wellness Key Strategic Growth industry, aligned brand partnerships and Pillar product innovation and expanded offering for Includes USPA & Evolis IP, clients and
Slide 14: Delivering our Brands to the Consumer
Delivering our Brands to the Consumer 380 loyal and passionate salon and spa partners, 7 professional ‘E-tailers’ and BLC owned websites to support our exclusive brands and strengthen unique brand Long Term Royalty Income Stream positioning in the professional market. 2024 consolidated strong strate
Slide 15: Sandy Beard, Chair
Sandy Beard Chair Anagenics Ltd. Ph: 0412 308 263 E: sandy@xvgroup.com.au